Table 2.
Group | Author | Country | No. of isolates | Type I No. (%) |
Type II No. (%) |
Type III No. (%) |
Mix/recombinant, Africa I and atypical No. (%) |
---|---|---|---|---|---|---|---|
Congenital | Howe and Sibley [13] | USA | 41 | 10 (24.4) | 25 (61) | 6 (14.6) | |
Ajzenberg et al. [14] | France | 86 | 7 (8.1) | 73 (84.9) | 2 (2.3) | 4 (4.6) atypical | |
Ferreira et al. [23] | Brazil | 4 | 4 (100) atypical | ||||
Nowakowske et al. [17] | Poland | 9 | 9 (100) | ||||
Djurković-Djaković et al. [18] | Serbia | 1 | 1 (100) | ||||
Demar et al. [20] | French Guiana | 3 | 3 (100) atypical | ||||
Boughattes et al. [22] | Tunisia | 14 | 1 (7.1) | 13 (50) mix/recombinant | |||
Boughattes et al. [24] | Tunisia | 1 | 1 (100) mix/recombinant | ||||
Boughattes et al. [24] | Tunisia | 1 | 1 (100) atypical | ||||
Costache et al. [29] | Romania | 1 | 1 (100) | ||||
Pardini et al. [31] | Argentina | 1 | 1 (100) | ||||
Döşkaya et al. [30] | Turkey | 2 | 2 (100) Africa I | ||||
Yera et al. [34] | French Polynesia | 2 | 2 (100) atypical | ||||
Vilares et al. [37] | Portugal | 48 | 6 (12.5) | 32 (66.7) | 10 (20.8) mix/recombinant | ||
Total | 214 | 24 (11.2) | 133 (62.1) | 17 (7.9) | 24 (11.2) mix/recombinant, 14 (6.5) atypical, 2 (0.9) Africa I | ||
AIDS | Howe and Sibley [13] | USA | 27 | 6 (20) | 18 (70) | 3 (10) | |
Genot et al. [19] | France | 1 | 1 (100) mix/recombinant | ||||
Total | 28 | 6 (21.4) | 18 (64.3) | 3 (10.7) | 1 (3.6) mix/recombinant | ||
Ocular | Grigg et al. [9] | France | 12 | 3 (25) | 3 (25) | 1 (8.4) | 5 (41.7) mix/recombinant |
Khan et al. [16] | Brazil | 11 | 3 (27.2) | 2 (18.2) | 3 (27.2) | 3 (27.2) mix/recombinant | |
Fekkar et al. [26] | France | 13 | 10 (77) | 1 (7.7) mix/recombinant, 2 (15.4) Africa I | |||
Total | 36 | 6 (16.7) | 15 (41.7) | 4 (11.1) | 9 (22.2) mix/recombinant, 2 (5.6) Africa I | ||
Immunocompetent | Demar et al. [20] | French Guiana | 8 | 8 (100) atypical | |||
Total | 286 | 36 (12.6) | 166 (58) | 24 (8.4%) | 34 (11.9) mix/recombinant, 22 (7.7) atypical, 4 (1.4) Africa I |